Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

6 months ago
R&D
AI

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

6 months ago
Deals
R&D

GSK snags Parkin­son's drug from Flag­ship start­up Vesal­ius

6 months ago
Startups
Deals

Neu­ro­gene's stock falls in post-mar­ket trad­ing af­ter ear­ly da­ta in Rett syn­drome

6 months ago
R&D
Cell/Gene Tx

23andMe to shut down its ther­a­peu­tics di­vi­sion

6 months ago
Pharma
Health Tech

Rapt cuts im­munol­o­gy pro­gram fol­low­ing clin­i­cal holds

6 months ago
Pharma
FDA+

FDA lifts hold on No­vavax vac­cines af­ter ad­verse event re­clas­si­fied as ALS

6 months ago
R&D
Pharma

Ther­mo Fish­er con­sol­i­dates vi­ral vec­tor work in Mass­a­chu­setts, cuts 160 work­ers 

6 months ago
People
Manufacturing

Yorvipath’s ap­proval show­cas­es bio­phar­ma’s in­ter­est in rare en­docrine dis­or­der

6 months ago
Startups
R&D

As­ser­tio de­nies ac­tivist in­vestor's claims of fraud in open let­ter

6 months ago
R&D

Crown jew­el from Ab­b­Vie's Cerev­el buy­out fails two Phase 2 schiz­o­phre­nia tests, Bris­tol My­er­s' stock soars

6 months ago
R&D

Cigna says it will not pur­sue a merg­er with Hu­mana

6 months ago
Deals
Health Tech

Dan­ish com­pa­ny pays $145M up­front to li­cense nasal spray al­ter­na­tive to EpiPen

6 months ago
Deals
Pharma

Cell ther­a­py star­tup's IPO plans thrown in lim­bo amid le­gal spat with in­vestor Al­con

6 months ago
Cell/Gene Tx
Law

Up­dat­ed: FDA ap­proves Au­to­lus’ CAR-T cell ther­a­py for ag­gres­sive blood can­cer

7 months ago
Pharma
Cell/Gene Tx

How Trump, RFK Jr. could in­flu­ence bio­phar­ma; Viking presents weight loss da­ta; Are MASH drugs get­ting boxed out by ...

7 months ago
Weekly

FDA records re­quest lands Chi­nese API man­u­fac­tur­er on blocked im­port list

7 months ago
Pharma
FDA+

GSK leaves biotech trade group BIO

7 months ago
Pharma

Am­gen and As­traZeneca share pos­i­tive re­sults in chron­ic rhi­nos­i­nusi­tis

7 months ago
R&D
Pharma

Ei­sai slash­es Leqem­bi sales fore­cast by al­most $100M

7 months ago
Pharma

Charles Riv­er to close ‘15 small­er sites’ as de­mand for ear­ly re­search de­clines

7 months ago
R&D
Outsourcing

Dai­ichi, Al­teogen to work on sub­cu­ta­neous En­her­tu; Roche ends Nykode deal

7 months ago
News Briefing

Benev­o­len­tAI’s co-founder is back. Here’s how he plans a turn­around at the AI com­pa­ny dur­ing a ‘piv­otal time’

7 months ago
AI

Leg­end names a pres­i­dent of Carvyk­ti; No­vo Nordisk's top North Amer­i­ca ex­ec is step­ping down

7 months ago
Peer Review
First page Previous page 78798081828384 Next page Last page
A service from the Financial Times